Page 3 - Development Generation Efficiency News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Published: Dec 21, 2020 Autobahn Labs and UCSF will establish new ventures for drug discovery and development PALO ALTO, Calif. and SAN FRANCISCO, Dec. 21, 2020 /PRNewswire/ -- Autobahn Labs, a virtual incubator partnering with top academic and research institutions to catalyze early-stage drug discovery and development, today announced a strategic collaboration with the University of California San Francisco (UCSF). The organizations will partner to identify promising early science with significant therapeutic potential, forming jointly owned ventures to accelerate the translation of s...

Autobahn Collaboration to Accelerate UCSF Innovation from Bench to Bedside By Nicholas Weiler on December 18, 2020 Partnership with Autobahn Labs Aims to Pave Road Through ‘Valley of Death’ Faced by Novel Therapies Through its Office of Innovation Ventures, UC San Francisco has formalized a new strategic collaboration with Autobahn Labs, a “virtual incubator” focused on drug discovery and development, to help move scientific discoveries with therapeutic potential more quickly to market. “The goal of Innovation Ventures is to help UCSF faculty and students transition their innovatio...

Share: PALO ALTO, Calif. and SAN FRANCISCO, Dec. 21, 2020 /PRNewswire/ -- Autobahn Labs, a virtual incubator partnering with top academic and research institutions to catalyze early-stage drug discovery and development, today announced a strategic collaboration with the University of California San Francisco (UCSF). The organizations will partner to identify promising early science with significant therapeutic potential, forming jointly owned ventures to accelerate the translation of scientific ideas to novel therapeutics. "UCSF combines world-class medicine, cutting-edge research, and a st...

Autobahn Labs announces a strategic drug discovery partnership with UCSF Autobahn Labs, a virtual incubator partnering with top academic and research institutions to catalyze early-stage drug discovery and development, today announced a strategic collaboration with the University of California San Francisco (UCSF). The organizations will partner to identify promising early science with significant therapeutic potential, forming jointly owned ventures to accelerate the translation of scientific ideas to novel therapeutics. "UCSF combines world-class medicine, cutting-edge research, and a stron...